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ABSTRACT: A set of azoheteroarenes have been synthesized with Buchwald−Hartwig
coupling and microwave-assisted O2 oxidation as the key steps. Several compounds
exhibit good to excellent photoswitching properties (high switching eﬃciency, good
fatigue resistance, and thermal stability of Z-isomer) relevant for photocontrolled
applications, which pave the way for use in photopharmacology.
Photoswitches have long held the interest of the scientiﬁccommunity for their ability to alter molecular structure,
and thus properties, using light as a stimulus.1−5 By
introducing photoswitches into bioactive molecules, their
biological activities can be switched on or oﬀ upon
photoisomerization between the implicated isomeric forms.6,7
In this way, photocontrolled regulators of ion channels,8
enzymes,9 receptors,10 as well as living organisms11 have been
developed. Such photoresponsive molecules are powerful tools
for studying living systems as they are noninvasive and oﬀer a
high spatiotemporal resolution.11−14 Azobenzene-based mo-
lecular photoswitches (Scheme 1a) have been extensively used
in such developments.15 Potential future applications of this
class of photoswitches include also optically controlled (bio-)
materials and information/data processing to mention a few.16
Of particular interest for the latter are compounds displaying
very fast thermal Z → E isomerization, allowing for ultrafast
data transmission.17
Nitrogen heterocycles are among the most signiﬁcant
structural components of pharmaceuticals.18 Therefore, in
order to integrate the azobenzene-based molecular photo-
switches into the pharmacophore of small drug-like molecules,
e.g., kinase inhibitors, the development of heterocyclic
azobenzene derivatives are fundamental.
Despite this fact, only a small portion of all heterocycles have
been used in photoswitchable heterocyclic azoswitches. Some
heterocyclic azo compounds have been well-studied,19−29
while others have been reported without mentioning photo-
physics/photochemistry.30,31 The classic strategies for synthe-
sizing azobenzenes include the Azo-coupling reaction, Mills
reaction, as well as metal=catalyzed coupling accompanied by
oxidation.32 An eﬃcient synthesis of red-shifted azo-benzenes
was recently introduced by the coupling between ortho-
lithiated aromatic precursors and aryldiazonium salts.4 In
regard to heterocyclic azobenzene derivatives, a phenyl-
azoimidazole,19 azoheteroarenes with methylated ﬁve-mem-
bered heterocyclic rings,19,28 including imidazoles,21 have been
reported using diazonium couplings.
Herein, we report on the synthesis and the photophysical
characterization of a series of azoheteroarenes, with Buch-
wald−Hartwig coupling or nucleophilic substitution, followed
by O2 oxidation as the key synthetic steps in the preparation of
the target compounds (Scheme 1b).
Pyridine and indole are among the most common aromatic
heterocycles in kinase inhibitors. Therefore, we opted for the
preparation of pyridine and indole-based azaanalogues,
including purine and quinazoline derivatives,33 to study how
the aromatic heterocycles inﬂuence the ease of synthesis and
photophysical properties of azoheteroarenes. All the selected
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Scheme 1. Photoswitches: (a) Azobenzene Photoswitches
and (b) Synthetic Strategy of Azoheteroarene Molecules
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target compounds contain heterocycles that are found in
reported kinase inhibitors (1a−1h; Table 1).
Bromoheterocycles 1a−1d (entries 1−3; Scheme 1) were
initially tested out using Buchwald−Hartwig conditions.34
Both 1a, 1b, and 1d substrates gave the target coupling
products 2a, 2b, and 3d in good yields. However, 1c
underwent signiﬁcant reduction of the aryl halide by β-
elimination35 during the coupling,36 and only a low yield of 2c
was obtained.
However, when 1e was submitted to this condition, no
product formation was observed. This was probably because
the secondary amine in the heterocycle interfered with the
coupling reaction. Therefore, we decided to block the function
of the secondary amine with an appropriate protecting group.
The Boc group could be installed on 5-bromoindole eﬃciently,
but the Boc group was cleaved under the coupling conditions.
Instead, we turned to tosyl, and 1e-2, 1f-2, 1g-2, and 1h-2
could be obtained in good to excellent yields (see Supporting
Information (SI)).37 When 1f-2 and 1g-2 (entries 6 and 7,
Table 1) were treated under standard Buchwald−Hartwig
coupling conditions, 2e−2g were obtained in good yield
(above 80%). However, the tosyl group on 1h-2 was unstable
under these conditions. Compound 1h was therefore protected
with THP38 to give 1h-3 (entry 8, Table 1) and then subjected
to the coupling condition to generate 2h in 42% isolated yield
(data not shown). When XPhos was employed as the ligand
instead of t-Bu3P·HBF4, the reaction completed and provided
coupling product 3h with a yield of 54%.
Inspired by work from the groups of Szymanski and
Feringa,22 we aimed at forming the azo bond with a “one-
pot, two-steps strategy”, more speciﬁcally, removing the Boc
group by microwave-assisted heating (above 150 °C)39 and
then oxidizing the hydrazine to give azo products with O2.
Several rounds of optimization resulted in a protocol giving
generally excellent yields (Table 1).
The tosyl group on 3e−3g could be removed by Cs2CO340
to give the corresponding heterocyclic azoarenes (5e−5g; see
SI) with a yield above 80%. The THP group on 3h was
deprotected by 4 M HCl in dioxane39 to provide 5h in 74%
yield.
Applying our developed Pd-mediated coupling strategy to 6-
Cl-9H-purine (1i) and 4-Cl-quinazoline (1j) gave no
detectable coupling products (see SI). Therefore, we turned
to take nucleophilic substitution as the key step.41−44
Compound 1i in n-BuOH, under an N2 atmosphere, was
treated with phenylhydrazine in the presence of DIPEA, using
microwave heating (150 °C, 2 h)22 followed by O2 treatment
to form the azo compound 6 (see SI) in 65% yield. When 1j
was treated with the same condition, no target product was
detected by LC−MS or 1H NMR. However, when changing
from n-BuOH to i-PrOH as solvent42 and heating at a lower
temperature (MW 60 °C, 30 min), followed by the O2
treatment, 8 was obtained in moderate yield (23%; see SI).
The photophysical properties of 3a−8 were then charac-
terized. The experimental results are shown only for 5e (Figure
1a, see SI for “enlarged” versions of all absorption spectra),
whereas the evaluated photophysical parameters for the whole
series are collected in Table 2. Water/DMSO has been used as
solvent. When the heterocyclic azo-switches get integrated
with phramacophores, water solubility could increase, thereby
excluding or minimizing the need of DMSO as cosolvent.
The initial absorption spectra, ascribed to 100% E-isomer,
were recorded after thermal adaption at 50 °C for 72 h. The
absorption maxima of the π → π* transition for the respective
compounds are observed at λ between 317 and 387 nm,
whereas the n → π* transitions at longer wavelengths are very
weak and barely seen in the absorption spectra. There is a clear
trend for the π → π* transition to redshift with increasing size
of the heterocycle. Leaving aside the protected compounds
(3e−3h) the monocyclic compounds display absorption
maxima between 317 and 328 nm, the bicyclic between 325
and 362 nm, and the tricyclic at 387 nm.
Introduction of the electron-withdrawing tosyl group results
in a blue shift of the absorption maxima (cf. 3e−3g and 5e−
5g) as well as signiﬁcant hyperchromism (see absorption
Table 1. Synthesis of Azoheteroarenes by Buchwald−
Hartwig Coupling and Oxidation
aUsing MW at 110 °C, the reaction was completed in 1.5 h. bBoc
deprotection and oxidation combined. cXPhos was used as ligand.
dMW, 200 °C, 30 min. eMW, 180 °C, 1 h, then 200 °C, 8 min; fMW,
160 °C, 2 h, then 180 °C, 30 min.
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spectra in the SI). Electron donation from a THP group (cf. 3h
and 5h) also results in hyperchromism but has no eﬀect on the
spectral position. The spectral shifts are supported by quantum
mechanical (DFT) calculations (see SI). Subsequent exposure
to UV light resulted in an increased absorption of the n → π*
transition at the expense of the π→ π* transition. All processes
proceeded with isosbestic points, which implies clean
conversion between the two implicated isomers. The wave-
lengths of the absorption maxima in the n → π* region are
collected in Table 2, together with the isomerization kinetics
and the photostationary distribution (PSD). Although no
attempts were made toward determining the isomerization
quantum yields, it is seen that the E→ Z isomerizations readily
proceed at the modest light intensities used in the experiments
(2−4 mW/cm2). At the PSD, samples 3a−5g are enriched in
the Z-form to between ca. 60% and almost full conversion.
Compounds 5h and 8 showed no detectable isomerization (see
below), while the thermal reversion for 6 was too fast to allow
for the determination of any reliable value.
Note that the PSDs were assessed in pure DMSO (Figure
1b) as opposed to water/DMSO. The values should, however,
be similar for the two solvent systems (Figure S39).
Table 2. Photophysical Properties
aWavelengths of the π→ π* transition of the E-isomer. bλmax in the n→ π* region at the photostationary distribution (PSD) after UV irradiation.
cIrradiation wavelengths used to enrich the samples in the Z- (longer wavelength light) and E-isomers (shorter wavelength light), respectively.
dPhotostationary distribution after photoisomerization to enrich the samples in the Z- and E-isomers, respectively. Tabulated as the fraction of the
Z-isomer. Determined in pure DMSO-d6.
eTime constants for the photoisomerization reactions, normalized to a common light density (365 nm:
2.5 mW/cm2, 405 nm: 4.0 mW/cm2, 460 nm: 3.0 mW/cm2). See SI for the original conditions used. fFraction of the sample isomerized in the
thermal Z → E reaction over 24 h. When isomerization is substantial, the corresponding time constant of the reaction is given.
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The majority of the compounds displays good thermal
stability, as less than 10% is isomerized back to the E- form
after 24 h in the dark. Exceptions are 3c, 3g, 3h, 5e, and 6
(Table 2). Compound 5g decomposes rapidly, tentatively
ascribed to hydrolysis. With the exception of 6, these are the
compounds with the lowest activation energies for thermal Z
→ E isomerization as estimated by DFT calculations assuming
thermal isomerization through inversion28,45 (see SI). The
discrepancy for 6 is tentatively ascribed to a diﬀerent
isomerization mechanism, rotation rather than inversion, as 6
together with 8 in the Z-form display the largest twisting angles
between the plane of the heterocycle and the N−N double
bond (see SI).
Compounds 5h and 8 were subjected to ns transient
absorption measurements. After the excitation pulse at 355 or
410 nm, the ground-state bleach recovery in the π→ π* region
was monitored and found to contain no detectable transients.
Thus, the only thing we can conclude is that if the absence of
detectable Z-isomers is due to thermal isomeriation Z → E it
must be faster than the time resolution of the experiment, i.e., a
few nanoseconds.
The photoinduced Z → E isomerizations were studied by
exposing the samples enriched in the Z-form to light in the
visible region, yielding PSD containing between 65% and 88%
of the E-isomer. The rates at which the isomerizations occur
show eﬃcient isomerization already at moderate light
intensities (1−4 mW/cm2). Except for 3f, no signiﬁcant
photodecomposition was observed upon photocycling (Figures
S15−S26).
In conclusion, we have synthesized a set of azoheteroarenes
mainly with a strategy using Buchwald−Hartwig coupling and
O2 oxidation as the key steps and commercially available
heterocyclic halogen as the starting substrates. The majority of
the compounds can be enriched in the Z-isomer to more than
90% using light at 365 or 405 nm, whereas the reverse
photoisomerization yields between 65% and 85% E-isomer at
the photostationary state using longer wavelength of light. The
thermal stability of the Z-isomer ranges between minutes to
months, and nearly all compounds have excellent photo-
stability. The relatively easy availability by synthesis together
with favorable photophysical properties make some of these
compounds promising candidates for future application in
photopharmacology, e.g., photoswitchable kinase inhibitors.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.or-
glett.8b02014.
Experimental procedures and UV−vis and NMR spectra
(PDF)
■ AUTHOR INFORMATION
Corresponding Authors
*E-mail: a-son@chalmers.se.
*E-mail: grotli@chem.gu.se.
ORCID
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